Article Versions Notes

Amioka K, Kawaoka T, Kinami T, Yamasaki S, Kosaka M, Johira Y, Yano S, Naruto K, Ando Y, Fujii Y, et al. Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma. Cancers. 2022; 14(20):5066. https://doi.org/10.3390/cancers14205066

Amioka, Kei, Tomokazu Kawaoka, Takahiro Kinami, Shintaro Yamasaki, Masanari Kosaka, Yusuke Johira, Shigeki Yano, Kensuke Naruto, Yuwa Ando, Yasutoshi Fujii, and et al. 2022. "Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma" Cancers 14, no. 20: 5066. https://doi.org/10.3390/cancers14205066

Amioka, K., Kawaoka, T., Kinami, T., Yamasaki, S., Kosaka, M., Johira, Y., Yano, S., Naruto, K., Ando, Y., Fujii, Y., Uchikawa, S., Ono, A., Yamauchi, M., Imamura, M., Kosaka, Y., Ohya, K., Mori, N., Takaki, S., Tsuji, K., ... Oka, S. (2022). Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma. Cancers, 14(20), 5066. https://doi.org/10.3390/cancers14205066